NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists weaponize Patients' own cells to attack Virus-Linked cancer
Disease control CompletedThis early-stage trial tested whether specially engineered immune cells could fight a type of head and neck cancer linked to Epstein-Barr virus. Researchers modified patients' own T-cells to recognize and attack cancer cells carrying the virus. The study involved 9 people with ad…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug combo trial targets Tough-to-Treat throat cancer
Disease control CompletedThis study tested a new combination of chemotherapy drugs (nab-paclitaxel, cisplatin, and fluorouracil) given before standard radiation and chemo in patients with advanced nasopharyngeal cancer. The goal was to see if this new drug sequence was safe and could shrink tumors more e…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug shows promise in keeping throat cancer at bay
Disease control CompletedThis study tested whether adding pembrolizumab (an immunotherapy drug) after standard chemoradiation could help prevent cancer from returning in patients with locally advanced nasopharyngeal carcinoma (a type of throat cancer). The trial involved 53 patients who received up to on…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New combo therapy tested for tough head & neck cancer
Disease control CompletedThis study tested whether adding an immunotherapy drug called nivolumab to standard chemotherapy and radiation treatment could better control nasopharyngeal cancer. It involved 40 adults with stage II-IVB cancer to see if the combined treatment was feasible and effective. The mai…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sue Yom • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New scan combo aims to spot hidden cancer spread
Diagnosis CompletedThis study aimed to find a better way to diagnose whether small lymph nodes in the neck contain cancer that has spread from nasopharyngeal carcinoma (a type of head and neck cancer). Researchers tested a combination of MRI scans and a special contrast-enhanced ultrasound on 348 p…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC